clinicalomicsprowebdirectory
News & Features
Topics
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Magazine
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News & Features
Translational Research
Precision Molecular Nabs Investment from ADDF for Development of More Effective…
Translational Research
Researchers Detail Mechanism for Clearing Misfolded Proteins at Root of Alzheimer’s…
Precision Medicine
Agendia Reports Positive Results in IMPACt Trial for Breast Cancer
Translational Research
Detailed Map of Breast Cancer Reveals the Effects of Mutations on…
Translational Research
Protein that Prevents Tau Clearance Linked to AD and Other Tau…
Topics
All
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Translational Research
Precision Molecular Nabs Investment from ADDF for Development of More Effective…
Translational Research
Researchers Detail Mechanism for Clearing Misfolded Proteins at Root of Alzheimer’s…
Precision Medicine
Agendia Reports Positive Results in IMPACt Trial for Breast Cancer
Translational Research
Detailed Map of Breast Cancer Reveals the Effects of Mutations on…
Magazine
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 1
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 5
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 4
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 3
Multimedia
All
Webinars
eBooks
Precision Medicine
From Bench to Clinic—The Potential of New Sequencing Tools
Precision Medicine
Mainstreaming Precision Oncology
eBooks
Better Understanding of Post-Translation Modifications Driving Innovation
Webinars
LeukoVantage: A Quest/QIAGEN Partnership Providing Clinical Insights Into Myeloid Malignancies
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Molecular Dx
Noninvasive Diagnostics
Noninvasive Diagnostics
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Noninvasive Diagnostics
NIPT Startup Cradle Genomics Closes $17.1M Series A Financing
July 16, 2019
Noninvasive Diagnostics
Illumina Prevails Against Ariosa in UK Patent Infringement Case
June 18, 2019
Noninvasive Diagnostics
Are Dogs the New Early Cancer Detection Tool?
June 18, 2019
Noninvasive Diagnostics
Invitae to Expand NIPS Services with Singular Bio Acquisition
June 17, 2019
Noninvasive Diagnostics
Thermo Fisher, NX Prenatal to Develop NIPT Proteomics Assays
April 17, 2019
Noninvasive Diagnostics
10-Minute Pan-Cancer Test Developed
December 5, 2018
Noninvasive Diagnostics
LGC Expands into Clinical Quality Control Tools with SeraCare Acquisition
November 26, 2018
Noninvasive Diagnostics
PerkinElmer, Hospital Partner on Clinical Trial of Vanadis NIPT Platform
July 10, 2018
Noninvasive Diagnostics
Myriad to Acquire Counsyl for $375M, Raising Presence in Women’s Health
May 29, 2018
Noninvasive Diagnostics
Annoroad Gene Technology Acquires 10 PacBio Sequel System Sequencers
March 27, 2018
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![One of the major scientific crusades in oncology has been to identify and validate biomarkers associated with recurrent breast cancer. [iStock / royaltystockphoto]](https://www.clinicalomics.com/wp-content/uploads/2019/01/585-218x150.jpeg "Agendia Reports Positive Results in IMPACt Trial for Breast Cancer")
![Berg will partner with Massachusetts General Hospital and Brigham and Women's Hospital to study potential biomarkers for Alzheimer's and other neurodegenerative disorders from Harvard Biomarker Study biospecimens. [Source: ajcity.net]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1397-218x150.jpeg "Protein that Prevents Tau Clearance Linked to AD and Other Tau Tangle Proteinopathies")
